MedTrace Logo

Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans

NCT01749826 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-01-30

Study results available
· View outcomes & findings →

Summary

We aim to examine the extent to which inflammation is affected by acute and chronic opioid exposure.

Conditions

Interventions

DRUG

Morphine Sulfate

15mg sustained release morphine sulfate, with a maximum dose of 120mg. Patients will be titrated up to a maximum dose of 8 pills a day for one month.

Sponsors & Collaborators

Principal Investigators

  • Dr Larry Fu-nien Chu · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01749826 on ClinicalTrials.gov